Financhill
Back

Kiniksa Pharmaceuticals Quote, Financials, Valuation and Earnings

Biden's Oil War: The Administration Is All-In on Green Energy.

Download Free Report
Buy
75

KNSA
Kiniksa Pharmaceuticals

Last Price:
19.55
Seasonality Move:
18.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Billionaire Investors Join Forces to Fund Next Generation

Learn More

Kiniksa Pharmaceuticals Price Quote

$19.55
-0.44 (-2.2%)
(Updated: March 28, 2024 at 12:45 PM ET)

Kiniksa Pharmaceuticals Key Stats

Buy
75
Kiniksa Pharmaceuticals (KNSA) is a Buy

Day range:
$19.88 - $20.16
52-week range:
$10.29 - $22.09
Dividend yield:
0%
P/E ratio:
99.95
P/S ratio:
5.35
P/B ratio:
3.22%

Volume:
330.1K
Avg. volume:
393.9K
1-year change:
75.97%
Market cap:
$1.4B
Revenue:
$270.3M
EPS:
$0.18

How Much Does Kiniksa Pharmaceuticals Make?

Is Kiniksa Pharmaceuticals Growing As A Company?

Kiniksa Pharmaceuticals Stock Price Performance

What Is Kiniksa Pharmaceuticals 52-Week High & Low?

Kiniksa Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Kiniksa Pharmaceuticals?

Is Kiniksa Pharmaceuticals Cash Flow Positive?

  • What Is KNSA Cash Flow From Operations?
    Cash flow from operations (TTM) is $13.3M
  • What Is Kiniksa Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.5M
  • What Is Kiniksa Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$29.6M

Kiniksa Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    KNSA return on invested capital is 3.45%
  • What Is Kiniksa Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 2.94%
  • What Is KNSA Return On Equity?
    ROE is a measure of profitability and is 3.45%

Kiniksa Pharmaceuticals Earnings Date & Stock Price

Kiniksa Pharmaceuticals Competitors

Kiniksa Pharmaceuticals Dividend Yield

Data Unavailable

Kiniksa Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 483.33% 488.89%
Revenue: 34.76% 15.39%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 27.80
Upside from Last Price: 39.07%

Major Shareholders

  • How many KNSA shares are owned by institutional investors?
    52.1M KNSA shares are owned by institutional investors
  • How many KNSA shares are owned by insiders?
    807K KNSA shares are owned by insiders